Effect of Fu's subcutaneous needling for cancer pain management: protocol for a pragmatic randomised controlled trial.

ABSTRACT:

Introduction

Pain is a common symptom in patients with cancer, and pain management is crucial for these patients. Fu's subcutaneous needling (FSN) is a modern acupuncture therapy based on basic medicine commonly used in patients with pain. However, evidence of its effectiveness in treating cancer pain has not been systematically proven. Therefore, this pragmatic randomised controlled trial aims to evaluate the effectiveness and safety of FSN for cancer pain management.

Methods and analysis

Overall, 120 eligible patients will be recruited and randomly assigned into two groups using block randomisation. Both groups will be administered analgesic drugs according to the National Comprehensive Cancer Network guidelines. The treatment group will receive FSN therapy one time a day

SUBMITTER: Xu D 

PROVIDER: S-EPMC10151994 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature